PLAUR and COVID-19: Identification of high plasma levels of soluble uPAR in severe COVID-19 patients and association of lower plasma levels of suPAR with favorable clinical outcomes offer a strong risk stratifier, which will be of great translational value for effective triage and optimal timing for critical care in the patients.